Jie Yu

Exploring the molecular pathways of Noncoding RNAs in ovarian cancer: insights into treatment resistance

Ovarian cancer ranks as the third most common gynecological malignancy, yet it has the highest mortality and recurrence rates among all gynecologic cancers. Chemotherapy combined with immunomodulators and targeted agents, including PTX, ADR, PARPi, and platinum-based chemotherape...